“Real-World Efficacy of Ramucirumab Plus Paclitaxel With or Without Nivolumab in Advanced Gastric and Gastroesophageal Junction Cancers”. 2026. Annals of Medical Research 33 (3): 091-098. http://www.annalsmedres.org/index.php/aomr/article/view/4905.